Delay discounting of gains and losses, glycemic control and therapeutic adherence in type 2 diabetes.
Behav Processes
; 132: 42-48, 2016 Nov.
Article
in En
| MEDLINE
| ID: mdl-27663668
ABSTRACT
OBJECTIVE:
Delay discounting is the tendency to prefer smaller, sooner rewards to larger, later ones. Poor adherence in type 2 diabetes could be partially explained by a discounted value of health, as a function of delay. Delay discounting can be described with a hyperbolic model characterized by a coefficient, k. The higher k, the less future consequences are taken into account when making decisions. This study aimed to determine whether k would be correlated with glycated hemoglobin and adherence in type 2 diabetes.METHODS:
Ninety-three patients were recruited in two diabetology departments. Delay discounting coefficients were measured with a computerized task. HbA1c was recorded and adherence was assessed by questionnaires. Potential socio-demographic and clinical confounding factors were collected.RESULTS:
There was a positive correlation between delay discounting of gains and HbA1c (r=0.242, P=0.023). This association remained significant after adjusting for potential confounding factors (F=4.807, P=0.031, η2=0.058). This association was partially mediated by adherence to medication (ß=0.048, 95% CI [0.004-0.131]).CONCLUSIONS:
Glycemic control is associated with delay discounting in patients suffering from type 2 diabetes. Should these findings be replicated with a prospective design, they could lead to new strategies to improve glycemic control among these patients.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Blood Glucose
/
Glycated Hemoglobin
/
Diabetes Mellitus, Type 2
/
Medication Adherence
/
Delay Discounting
Type of study:
Prognostic_studies
/
Qualitative_research
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Behav Processes
Year:
2016
Document type:
Article